NCT03148262

Brief Summary

It is standard practice in the United States and many parts of world to perform Gastrointestinal (GI) endoscopy with the patient under deep sedation. Obesity is accepted as a patient specific risk factor for hypoxic events during procedural sedation for GI endoscopic procedures. The Obese population has a higher prevalence of obstructive sleep apnea (OSA) which is characterized by repeated obstruction of the upper airway, and leads to apnea and desaturation. This prospective, randomized study was designed to compare the effectiveness of the high flow nasal cannula and the standard nasal cannula in morbidly obese (BMI \> 40) patients receiving deep intravenous sedation during colonoscopies. This study will assess whether use of the high flow nasal cannula (HFNC) leads to less intraoperative desaturation events compared to the current standard of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

May 10, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 22, 2018

Completed
10 months until next milestone

Results Posted

Study results publicly available

November 19, 2018

Completed
Last Updated

November 19, 2018

Status Verified

November 1, 2018

Enrollment Period

4 months

First QC Date

May 8, 2017

Results QC Date

June 6, 2018

Last Update Submit

November 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Number of Desaturation Episodes

    The number of desaturation episodes defined as blood oxygen saturation (SpO2) below 90% during the perioperative period during colonoscopy.

    Perioperative period during colonoscopy

Study Arms (2)

The high flow nasal cannula

EXPERIMENTAL

The Comfort Flo system will be used for the high flow nasal cannula during colonoscopy

Device: The Comfort Flo system

The standard nasal cannula

PLACEBO COMPARATOR

The Salter nasal cannula will be used during the colonoscopy

Device: The Salter nasal cannula

Interventions

The Comfort Flo system will be used for the high flow nasal cannula during procedural sedation

Also known as: High flow nasal cannula
The high flow nasal cannula

A Salter nasal cannula will be used at 4L/ minute during the procedural sedation.

Also known as: Standard nasal cannula
The standard nasal cannula

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18-80
  • Subjects undergoing colonoscopies
  • Morbidly obese BMI ≥ 40

You may not qualify if:

  • Subjects deemed hemodynamically unstable by the anesthesia team
  • Subjects who are an aspiration risk and will require endotracheal intubation.
  • Pregnancy
  • Subjects with an allergy to propofol
  • Patients who are unable to tolerate the high flow nasal cannula secondary to discomfort
  • Subjects unwilling to sign consent
  • Chronic obstructive pulmonary disease
  • Patients that received medications other than lidocaine and propofol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Parkland Helath Hospital System

Dallas, Texas, 75390, United States

Location

Parkland Hospital

Dallas, Texas, 75390, United States

Location

MeSH Terms

Conditions

ObesitySleep Apnea Syndromes

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Results Point of Contact

Title
Dr. Christina Riccio
Organization
UT Southwestern Medical Center

Study Officials

  • Amanda Fox, MD

    University of Texas Southwestern Medical Center

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 8, 2017

First Posted

May 10, 2017

Study Start

May 10, 2017

Primary Completion

August 28, 2017

Study Completion

January 22, 2018

Last Updated

November 19, 2018

Results First Posted

November 19, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations